Epstein-Barr viremia and post-transplant lymphoproliferative disorders in patients undergoing haploidentical stem cell transplantation with post-transplant cyclophosphamide

Saved in:
Bibliographic Details
Published inHematology/oncology and stem cell therapy Vol. 12; no. 3; pp. 171 - 173
Main Authors Mohyuddin, Ghulam Rehman, Roller, John, Shune, Leyla, Lin, Tara, Dias, Ajoy, Ganguly, Siddhartha, Abhyankar, Sunil, McGuirk, Joseph, Singh, Anurag
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.09.2019
Subjects
Cyclophosphamide - adverse effects
Cyclophosphamide - therapeutic use
Epstein-Barr Virus Infections - etiology
Female
Graft vs Host Disease - prevention & control
Hematopoietic Stem Cell Transplantation - adverse effects
Hematopoietic Stem Cell Transplantation - methods
Humans
Immunosuppressive Agents - adverse effects
Immunosuppressive Agents - therapeutic use
Lymphoproliferative Disorders - etiology
Male
Middle Aged
Viremia - etiology
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:1658-3876
DOI:10.1016/j.hemonc.2018.11.002